NASDAQ:WBA - Walgreens Boots Alliance Stock Price, Price Target & More

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance declared a quarterly dividend on Friday, June 29th. Stockholders of record on Monday, August 20th will be given a dividend of $0.44 per share on Wednesday, September 12th. This represents a $1.76 annualized dividend and a dividend yield of 2.70%. The ex-dividend date of this dividend is Friday, August 17th. This is an increase from Walgreens Boots Alliance's previous quarterly dividend of $0.40. View Walgreens Boots Alliance's Dividend History.

Walgreens Boots Alliance declared that its board has approved a share repurchase program on Thursday, October 26th 2017, which permits the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's management believes its stock is undervalued.

Walgreens Boots Alliance Inc (NASDAQ:WBA) released its quarterly earnings data on Thursday, June, 28th. The pharmacy operator reported $1.53 earnings per share for the quarter, beating analysts' consensus estimates of $1.47 by $0.06. The pharmacy operator earned $34.33 billion during the quarter, compared to the consensus estimate of $34.15 billion. Walgreens Boots Alliance had a net margin of 3.36% and a return on equity of 21.22%. The firm's revenue was up 14.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.33 earnings per share. View Walgreens Boots Alliance's Earnings History.

Walgreens Boots Alliance issued an update on its FY18 earnings guidance on Thursday, June, 28th. The company provided earnings per share (EPS) guidance of $5.90-6.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.95.

18 brokerages have issued twelve-month target prices for Walgreens Boots Alliance's stock. Their forecasts range from $60.00 to $96.00. On average, they expect Walgreens Boots Alliance's share price to reach $77.0588 in the next year. This suggests a possible upside of 18.4% from the stock's current price. View Analyst Ratings for Walgreens Boots Alliance.

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 1 sell rating, 11 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Walgreens Boots Alliance saw a increase in short interest during the month of June. As of June 15th, there was short interest totalling 17,165,556 shares, an increase of 15.9% from the May 31st total of 14,810,457 shares. Based on an average daily trading volume, of 5,380,135 shares, the short-interest ratio is presently 3.2 days. Currently, 2.0% of the shares of the company are short sold. View Walgreens Boots Alliance's Current Options Chain.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Media stories about WBA stock have been trending somewhat positive this week, according to Accern Sentiment. The research group scores the sentiment of news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Walgreens Boots Alliance earned a news impact score of 0.09 on Accern's scale. They also assigned news articles about the pharmacy operator an impact score of 48.13 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Walgreens Boots Alliance's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Bank of Montreal Can (0.17%), Hexavest Inc. (0.14%), Gateway Investment Advisers LLC (0.07%), Riverbridge Partners LLC (0.05%), DnB Asset Management AS (0.04%) and Chesley Taft & Associates LLC (0.03%). Company insiders that own Walgreens Boots Alliance stock include Janice M Babiak, John Anthony Lederer, Kathleen Wilson-Thompson, Ornella Barra, Stefano Pessina and William C Foote. View Institutional Ownership Trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Guidant Wealth Advisors, Grassi Investment Management, Gofen & Glossberg LLC IL, Bath Savings Trust Co, Riverbridge Partners LLC, Park National Corp OH, Vigilant Capital Management LLC and Newman Dignan & Sheerar Inc.. View Insider Buying and Selling for Walgreens Boots Alliance.

WBA stock was acquired by a variety of institutional investors in the last quarter, including Bank of Montreal Can, DnB Asset Management AS, Manning & Napier Group LLC, Cardinal Capital Management Inc., Founders Capital Management LLC, Gateway Investment Advisers LLC, Kempner Capital Management Inc. and Tandem Investment Advisors Inc.. Company insiders that have bought Walgreens Boots Alliance stock in the last two years include Janice M Babiak, John Anthony Lederer, Ornella Barra and Stefano Pessina. View Insider Buying and Selling for Walgreens Boots Alliance.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WBA stock can currently be purchased for approximately $65.10.

Walgreens Boots Alliance has a market capitalization of $64.68 billion and generates $118.21 billion in revenue each year. The pharmacy operator earns $4.08 billion in net income (profit) each year or $5.10 on an earnings per share basis. Walgreens Boots Alliance employs 345,000 workers across the globe.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at 847-315-2500 or via email at [email protected]